NXC-201 is a sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy. Initial data from Phase 1b/2 ex-U.S. study NEXICART-1 has demonstrated high complete response rates ...

- Dan Monahan will lead the commercialization strategy across Amylyx’ product portfolio, beginning with avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor ...

Viewers who enjoyed Netflix's thriller movie Carry-On have several upcoming Taron Egerton films and a brand-new television ...

Horror had a banner year in 2024. Several indie movies became surprise smash hits, from Strange Darling's word-of-mouth ...

A new year beckons new resolutions. At the risk of sounding like a stubborn old relic who resists change, I resolve to have ...

And after a quick glance at the 2025 calendar, the major studios still seem to be in recovery mode, reverting to familiar ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

UnitedHealth Group ( NYSE: UNH) Chief Executive Andrew Witty has been telling executives and rank-and-file staffers that ...

Each week our staff of film and television experts surveys the entertainment landscape to select the ten best new/newish ...

In typical Canadian-film fashion, many of the movies below have already come and gone from the big screen, or won’t make the ...

And if you're curious, check out my top 10 books of 2023! 1.The Will of the Many by James Islington One thing about me is if there's an academy involved with a cutthroat, life-threatening competition ...